SYNERGIE GENE+ OUTCOMES Trademark

Trademark Overview

On Friday, June 23, 2023, a trademark application was filed for SYNERGIE GENE+ OUTCOMES with the United States Patent and Trademark Office. The USPTO has given the SYNERGIE GENE+ OUTCOMES trademark a serial number of 98055817. The federal status of this trademark filing is REGISTERED as of Tuesday, January 7, 2025. This trademark is owned by Synergie Medication Collective, LLC. The SYNERGIE GENE+ OUTCOMES trademark is filed in the Advertising, Business and Retail Services category with the following description:

Administering discount group purchasing programs, namely, facilitating and negotiating gene therapy outcomes-based contracts with pharmaceutical manufacturers that require longitudinal patient tracking to assess therapy efficacy and durability, and value-based warranty payments to a risk pool to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or service
synergie gene+ outcomes

General Information

Serial Number98055817
Word MarkSYNERGIE GENE+ OUTCOMES
Filing DateFriday, June 23, 2023
Status700 - REGISTERED
Status DateTuesday, January 7, 2025
Registration Number7645616
Registration DateTuesday, January 7, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements

Pseudo MarkSYNERGIE GENE AND OUTCOMES; SYNERGIE GENE PLUS OUTCOMES
Goods and ServicesAdministering discount group purchasing programs, namely, facilitating and negotiating gene therapy outcomes-based contracts with pharmaceutical manufacturers that require longitudinal patient tracking to assess therapy efficacy and durability, and value-based warranty payments to a risk pool to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or service
NOT AVAILABLE"OUTCOMES"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, July 25, 2023
Primary Code035
First Use Anywhere DateFriday, December 15, 2023
First Use In Commerce DateFriday, December 15, 2023

Trademark Owner History

Party NameSynergie Medication Collective, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19801
Party NameSynergie Medication Collective, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19801
Party NameSynergie Medication Collective, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19801

Trademark Events

Event DateEvent Description
Tuesday, September 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 27, 2023NEW APPLICATION ENTERED
Tuesday, July 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Tuesday, September 26, 2023NON-FINAL ACTION WRITTEN
Tuesday, September 26, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 16, 2024USE AMENDMENT FILED
Monday, September 16, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, November 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, November 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 16, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, December 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 7, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 7, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

outcomes gene synergie based therapy participating benefit plan enable pool value warranty payments